1) Ex-NBA baller Samaki Walker popped in Arizona trying to eat ten grams of pot — which is a lot. Plus he had steroids and pills.
2) Time magazine writes about a component in marijuana, CBD, that dramatically reduces cocaine consumption in mice. (Plus it may prevent the development of the brain plaques associated with Alzheimer's disease. It also seems to have antipsychotic effects.) ProjectCBD in the East Bay is on a mission to identify CBD-rich strains, like Harlequin.
4) As medical marijuana use rises, teen use falls? A new survey from the Substance Abuse and Mental Health Services Administration shows more Americans smoking pot, except for teens. Whuh? (Raw Story)
5) Meanwhile, the D.E.A. wins hearts and minds in Detroit.
6) Arizona Governor Jan Brewer's plan to stall medical marijuana with a federal lawsuit is not a "proper subject for litigation," writes Deputy U.S. Attorney Scott Risner in a letter asking U.S. District Court Judge Susan Bolton to throw the suit out. State Attorney General Tom Horne, another foe of the successful voter initiative, intends to keep holding up the state's dispensary program. The ACLU is also arguing alongside the U.S. government to have Brewer and Horne's suit dismissed. (Ahwatukee Foothills News)
7) Medical marijuana patient lobbying group Americans for Safe Access is also suing over Brewer's stalling. "We'd like to believe Governor Brewer has the best interest of Arizonans at heart," said ASA Executive Director Steph Sherer. "But her opposition to medical cannabis is well known, and this is a way to stall implementation."
8) Lastly, California Attorney General Kamala Harris' draft guidelines for medical marijuana equal more red tape for patients, caregivers, growers and collectives, Examiner succinctly summarizes:
Provisions in a draft of Attorney General Kamala Harris’ medical marijuana guidelines raise questions and concerns. Here are some of them:
A cultivator should sell to only one dispensary: This provision would help keep marijuana from being used for nonmedical purposes, but critics say it could increase costs, limit product availability and hurt smaller dispensaries.
People should buy medical marijuana from only one dispensary: Limiting where patients can buy could subject them to higher prices and also limit access to different products.